HMRI Infection Research Program

Infectious diseases continue to pose a significant threat to public health. The COVID-19 pandemic underscored how quickly societies can become vulnerable to emerging pathogens. Factors such as increasing population density and global warming further elevate the risk of outbreaks, highlighting the urgent need for effective preparedness and response strategies.

Antimicrobial resistance is another major concern. The widespread and often unnecessary use of antibiotics accelerates the development of resistant strains, undermining the effectiveness of treatments for severe bacterial infections. These resistant organisms, along with other pathogens, are frequently encountered in healthcare settings, placing additional strain on our health systems.

In addition to preventing and detecting infectious diseases, there is currently a lack of evidence-based guidelines to effectively treat serious infections such as sepsis and prosthetic joint infections, where timely and targeted therapy is critical to patient outcomes.

The Infection Research Program at HMRI brings together multidisciplinary experts to address these critical challenges. Our focus spans across four key research themes, investigating multiple areas including antimicrobial resistance, infection prevention, emerging pathogens, vaccine development, treatment innovation, and public health surveillance.

We are committed to translating scientific discoveries into real-world solutions to improve health outcomes both locally and globally.